Cargando…
Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs
BACKGROUND: The sand flea Tunga penetrans is one of the agents of tungiasis, an important parasitic skin disease affecting humans and several mammalian species. Tungiasis is mainly observed in disadvantaged rural and peripheral urban communities in Latin America and sub-Saharan Africa. The dog is a...
Autores principales: | , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693705/ https://www.ncbi.nlm.nih.gov/pubmed/38042848 http://dx.doi.org/10.1186/s13071-023-06063-x |
_version_ | 1785153219290202112 |
---|---|
author | dos Santos, Katharine Costa Tielemans, Eric Cutolo, Andre Antonio Guedes, Paula Elisa Brandão Harvey, Tatiani Vitor de Carvalho Teixeira, Jamille Bispo Vitor, Rebeca Costa da Paixão Sevá, Anaiá de Melo Navarro, Adan William Lima, Ana Carolina Ribeiro Botteon, Karin Denise Bittar, Thammy Vieira Albuquerque, George Rêgo de Almeida Borges, Fernando Beugnet, Frederic Carlos, Renata Santiago Alberto |
author_facet | dos Santos, Katharine Costa Tielemans, Eric Cutolo, Andre Antonio Guedes, Paula Elisa Brandão Harvey, Tatiani Vitor de Carvalho Teixeira, Jamille Bispo Vitor, Rebeca Costa da Paixão Sevá, Anaiá de Melo Navarro, Adan William Lima, Ana Carolina Ribeiro Botteon, Karin Denise Bittar, Thammy Vieira Albuquerque, George Rêgo de Almeida Borges, Fernando Beugnet, Frederic Carlos, Renata Santiago Alberto |
author_sort | dos Santos, Katharine Costa |
collection | PubMed |
description | BACKGROUND: The sand flea Tunga penetrans is one of the agents of tungiasis, an important parasitic skin disease affecting humans and several mammalian species. Tungiasis is mainly observed in disadvantaged rural and peripheral urban communities in Latin America and sub-Saharan Africa. The dog is a major reservoir of Tunga fleas. Hematophagous adult female Tunga spp. embed and grow in their host’s epidermis and cause cutaneous inflammatory disorders. NexGard Spectra(®) is an orally administered endectocide for dogs, a co-formulation of the isoxazoline afoxolaner and the macrocyclic lactone milbemycin oxime. The objective of this study was to assess the efficacy of this product against canine tungiasis. METHODS: A blinded, negative-controlled field trial was conducted in a Brazilian community known to be highly endemic for tungiasis. Sixty-six dogs naturally infected with live T. penetrans were randomly allocated to a treated group (44 dogs) and an untreated control group (22 dogs). In a first phase, dogs from the treated group were treated on days 0, 30, and 60. Efficacy was evaluated on the basis of the macroscopic parasitic skin lesions (Fortaleza classification) on days 7, 14, 21, 30, 45, 60, 75, and 90. In a second phase, to evaluate natural reinfections, all dogs were treated on day 90 and evaluated every 2 weeks thereafter until at least 30% of dogs were infected with live sand fleas. RESULTS: During the first phase, efficacy (reduction in live sand fleas) of 92.4% was demonstrated on day 7. From day 14 until day 90, the efficacy of NexGard Spectra(®) was 100%. In the second phase, all dogs were free of live T. penetrans from 15 until 45 days after the day 90 treatment; 60 days post-treatment, 11% of dogs were reinfected, and 75 days post-treatment, 40% of dogs were reinfected. CONCLUSIONS: NexGard Spectra(®) was demonstrated to be highly effective against canine tungiasis. In addition to an obvious beneficial effect on the health and welfare of the treated dog, the use of this product may have a one-health benefit on human cases by controlling the main reservoir of sand fleas. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10693705 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-106937052023-12-04 Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs dos Santos, Katharine Costa Tielemans, Eric Cutolo, Andre Antonio Guedes, Paula Elisa Brandão Harvey, Tatiani Vitor de Carvalho Teixeira, Jamille Bispo Vitor, Rebeca Costa da Paixão Sevá, Anaiá de Melo Navarro, Adan William Lima, Ana Carolina Ribeiro Botteon, Karin Denise Bittar, Thammy Vieira Albuquerque, George Rêgo de Almeida Borges, Fernando Beugnet, Frederic Carlos, Renata Santiago Alberto Parasit Vectors Research BACKGROUND: The sand flea Tunga penetrans is one of the agents of tungiasis, an important parasitic skin disease affecting humans and several mammalian species. Tungiasis is mainly observed in disadvantaged rural and peripheral urban communities in Latin America and sub-Saharan Africa. The dog is a major reservoir of Tunga fleas. Hematophagous adult female Tunga spp. embed and grow in their host’s epidermis and cause cutaneous inflammatory disorders. NexGard Spectra(®) is an orally administered endectocide for dogs, a co-formulation of the isoxazoline afoxolaner and the macrocyclic lactone milbemycin oxime. The objective of this study was to assess the efficacy of this product against canine tungiasis. METHODS: A blinded, negative-controlled field trial was conducted in a Brazilian community known to be highly endemic for tungiasis. Sixty-six dogs naturally infected with live T. penetrans were randomly allocated to a treated group (44 dogs) and an untreated control group (22 dogs). In a first phase, dogs from the treated group were treated on days 0, 30, and 60. Efficacy was evaluated on the basis of the macroscopic parasitic skin lesions (Fortaleza classification) on days 7, 14, 21, 30, 45, 60, 75, and 90. In a second phase, to evaluate natural reinfections, all dogs were treated on day 90 and evaluated every 2 weeks thereafter until at least 30% of dogs were infected with live sand fleas. RESULTS: During the first phase, efficacy (reduction in live sand fleas) of 92.4% was demonstrated on day 7. From day 14 until day 90, the efficacy of NexGard Spectra(®) was 100%. In the second phase, all dogs were free of live T. penetrans from 15 until 45 days after the day 90 treatment; 60 days post-treatment, 11% of dogs were reinfected, and 75 days post-treatment, 40% of dogs were reinfected. CONCLUSIONS: NexGard Spectra(®) was demonstrated to be highly effective against canine tungiasis. In addition to an obvious beneficial effect on the health and welfare of the treated dog, the use of this product may have a one-health benefit on human cases by controlling the main reservoir of sand fleas. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2023-12-02 /pmc/articles/PMC10693705/ /pubmed/38042848 http://dx.doi.org/10.1186/s13071-023-06063-x Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research dos Santos, Katharine Costa Tielemans, Eric Cutolo, Andre Antonio Guedes, Paula Elisa Brandão Harvey, Tatiani Vitor de Carvalho Teixeira, Jamille Bispo Vitor, Rebeca Costa da Paixão Sevá, Anaiá de Melo Navarro, Adan William Lima, Ana Carolina Ribeiro Botteon, Karin Denise Bittar, Thammy Vieira Albuquerque, George Rêgo de Almeida Borges, Fernando Beugnet, Frederic Carlos, Renata Santiago Alberto Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs |
title | Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs |
title_full | Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs |
title_fullStr | Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs |
title_full_unstemmed | Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs |
title_short | Efficacy of an oral formulation of afoxolaner and milbemycin oxime against Tunga penetrans in naturally infected dogs |
title_sort | efficacy of an oral formulation of afoxolaner and milbemycin oxime against tunga penetrans in naturally infected dogs |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10693705/ https://www.ncbi.nlm.nih.gov/pubmed/38042848 http://dx.doi.org/10.1186/s13071-023-06063-x |
work_keys_str_mv | AT dossantoskatharinecosta efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT tielemanseric efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT cutoloandreantonio efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT guedespaulaelisabrandao efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT harveytatianivitor efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT decarvalhoteixeirajamillebispo efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT vitorrebecacosta efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT dapaixaosevaanaia efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT demelonavarroadanwilliam efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT limaanacarolinaribeiro efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT botteonkarindenise efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT bittarthammyvieira efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT albuquerquegeorgerego efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT dealmeidaborgesfernando efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT beugnetfrederic efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs AT carlosrenatasantiagoalberto efficacyofanoralformulationofafoxolanerandmilbemycinoximeagainsttungapenetransinnaturallyinfecteddogs |